Related Experiment Videos
Lead blood concentrations and renal function evaluation: study in an exposed Mexican population
Maria I Hernández-Serrato1, Teresa Imelda Fortoul, Rosalba Rojas-Martínez
1Instituto Nacional de Salud Pública, Cuernavaca, México.
Environmental Research
|January 31, 2006
Summary
Elevated blood lead (Pb) levels in Oaxaca, Mexico, are linked to kidney dysfunction, particularly in male glazed pottery workers. Higher lead exposure correlates with increased risk of hyperuricemia and altered serum creatinine (SCr) levels.
Area of Science:
- Environmental Health
- Toxicology
- Nephrology
Background:
- Lead (Pb) exposure is a known risk factor for renal dysfunction, including interstitial fibrosis, tubular atrophy, and reduced glomerular filtration.
- Previous studies have established a link between blood Pb concentrations and adverse kidney outcomes.
Purpose of the Study:
- To analyze blood Pb concentrations and renal function tests in a population from Oaxaca, Mexico.
- To identify factors associated with elevated blood Pb levels and their impact on renal function markers.
Main Methods:
- Cross-sectional analysis of blood Pb concentrations and renal function tests (uric acid, serum creatinine [SCr]).
- Statistical analysis to determine associations between Pb levels, demographic factors, occupation, and renal function parameters.
- Calculation of odds ratios (OR) and confidence intervals (CI) for hyperuricemia.
Main Results:
- Males exhibited higher blood Pb concentrations than females (P<0.0012).
- Occupation (glazed pottery workers, P=0.0001) and use of glazed pottery for cooking (P=0.0000) were primary associated variables.
- Blood Pb concentrations, sex, weight, and height explained 23% of uric acid variability (r2=0.23).
- Hyperuricemia was associated with blood Pb > 40 microg/dL (OR=1.74, 95% CI, 1.12-2.61).
- SCr levels were associated with sex, age, and blood Pb (r2=0.12).
Conclusions:
- Inadequate control of oven emissions in glazed pottery production may contribute to occupational and non-occupational lead exposure.
- Findings highlight the need for further analysis and preventive measures to protect the population from lead exposure, especially non-occupationally exposed individuals.
Related Concept Videos
01:17Factors Affecting Renal Clearance: Renal Impairment
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
01:24Serum Studies: Renal Function Tests
Renal function tests are crucial for assessing kidney health, monitoring disease progression, and evaluating the kidneys' efficiency in waste elimination, fluid balance, and electrolyte regulation. These tests offer critical insights into kidney function, even though routine measurements may appear normal until there is a significant decline in the glomerular filtration rate or GFR. Typically, signs of kidney impairment only become evident when the GFR falls to about 50% of its normal level.
01:25Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant
In patients with renal disease, dosage adjustments are necessary to maintain therapeutic plasma drug concentrations and prevent toxicity or subtherapeutic exposure. Renal impairment alters drug pharmacokinetics, especially in conditions like uremia, where changes such as prolonged elimination half-life and altered apparent volume of distribution can significantly affect drug disposition. These changes require careful modification of the dosing regimen to achieve the desired clinical...
01:28Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration
Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area. This equation is...
01:15Bioavailability Study Design: Healthy Subjects Versus Patients
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
01:25Drug Dosing in Renal Diseases: Measurement of Serum Creatinine Concentration and Clearance
In healthy individuals, serum creatinine levels remain stable due to a balance between its constant production—primarily from muscle metabolism—and renal excretion. Creatinine is freely filtered by the glomeruli, making it a valuable marker for estimating renal function. When the glomerular filtration rate (GFR) decreases, the kidneys can only eliminate less creatinine, causing serum levels to rise.Serum creatinine concentration is widely used to estimate creatinine clearance (Clcr), a...